• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

丝状病毒出血热的基本临床和实验室特征。

Basic clinical and laboratory features of filoviral hemorrhagic fever.

机构信息

Department of Preventive Medicine, Infectious Disease Clinical Research Program, Uniformed Services University of Health Sciences, Bethesda, Maryland 20814-5119, USA.

出版信息

J Infect Dis. 2011 Nov;204 Suppl 3:S810-6. doi: 10.1093/infdis/jir299.

DOI:10.1093/infdis/jir299
PMID:21987756
Abstract

The filoviruses Marburg and Ebola cause severe hemorrhagic fever (HF) in humans. Beginning with the 1967 Marburg outbreak, 30 epidemics, isolated cases, and accidental laboratory infections have been described in the medical literature. We reviewed those reports to determine the basic clinical and laboratory features of filoviral HF. The most detailed information was found in descriptions of patients treated in industrialized countries; except for the 2000 outbreak of Ebola Sudan HF in Uganda, reports of epidemics in central Africa provided little controlled or objective clinical data. Other than the case fatality rate, there were no clear differences in the features of the various filovirus infections. This compilation will be of value to medical workers responding to epidemics and to investigators attempting to develop animal models of filoviral HF. By identifying key unanswered questions and gaps in clinical data, it will help guide clinical research in future outbreaks.

摘要

马尔堡病毒和埃博拉病毒可引起人类严重的出血热(HF)。自 1967 年马尔堡病毒爆发以来,医学文献中已有 30 次暴发、孤立病例和意外实验室感染的描述。我们对这些报告进行了审查,以确定丝状病毒 HF 的基本临床和实验室特征。在描述在工业化国家治疗的患者时,可以找到最详细的信息;除了 2000 年乌干达爆发的埃博拉苏丹 HF 以外,在中非的疫情报告几乎没有提供任何对照或客观的临床数据。除了病死率之外,各种丝状病毒感染的特征没有明显差异。本汇编将对应对疫情的医务人员和试图开发丝状病毒 HF 动物模型的研究人员具有重要价值。通过确定关键的未解答问题和临床数据的空白,它将有助于指导未来疫情中的临床研究。

相似文献

1
Basic clinical and laboratory features of filoviral hemorrhagic fever.丝状病毒出血热的基本临床和实验室特征。
J Infect Dis. 2011 Nov;204 Suppl 3:S810-6. doi: 10.1093/infdis/jir299.
2
Ebola and marburg hemorrhagic fever.埃博拉和马尔堡出血热。
Clin Lab Med. 2010 Mar;30(1):161-77. doi: 10.1016/j.cll.2009.12.001.
3
[Ebola and Marburg hemorrhagic fever viruses: update on filoviruses].[埃博拉和马尔堡出血热病毒:丝状病毒最新情况]
Med Trop (Mars). 2011 Apr;71(2):111-21.
4
Lessons learned during active epidemiological surveillance of Ebola and Marburg viral hemorrhagic fever epidemics in Africa.在非洲对埃博拉和马尔堡病毒性出血热疫情进行主动流行病学监测期间汲取的经验教训。
East Afr J Public Health. 2010 Mar;7(1):30-6.
5
Other viral bioweapons: Ebola and Marburg hemorrhagic fever.其他病毒性生物武器:埃博拉出血热和马尔堡出血热。
Dermatol Clin. 2004 Jul;22(3):291-302, vi. doi: 10.1016/j.det.2004.03.003.
6
[Viral hemorrhagic fever--Ebola hemorrhagic fever, Marburg disease and Lassa fever].[病毒性出血热——埃博拉出血热、马尔堡病和拉沙热]
Rinsho Byori. 1998 Jul;46(7):651-5.
7
[Ebola and Marburg fever--outbreaks of viral haemorrhagic fever].[埃博拉和马尔堡热——病毒性出血热疫情]
Klin Mikrobiol Infekc Lek. 2006 Dec;12(6):217-23.
8
Case definition for Ebola and Marburg haemorrhagic fevers: a complex challenge for epidemiologists and clinicians.埃博拉出血热和马尔堡出血热的病例定义:对流行病学家和临床医生而言的一项复杂挑战。
New Microbiol. 2009 Oct;32(4):359-67.
9
Tissue and cellular tropism, pathology and pathogenesis of Ebola and Marburg viruses.埃博拉病毒和马尔堡病毒的组织和细胞嗜性、病理学和发病机制。
J Pathol. 2015 Jan;235(2):153-74. doi: 10.1002/path.4456.
10
Marburg and Ebola virus infections in laboratory non-human primates: a literature review.实验室非人灵长类动物中的马尔堡病毒和埃博拉病毒感染:文献综述
Comp Med. 2000 Apr;50(2):108-23.

引用本文的文献

1
Small molecule drug discovery for Ebola virus disease.针对埃博拉病毒病的小分子药物研发
RSC Med Chem. 2025 Aug 6. doi: 10.1039/d5md00533g.
2
Marburg Virus Disease: Pathophysiology, Diagnostic Challenges, and Global Health Preparedness Strategies.马尔堡病毒病:病理生理学、诊断挑战及全球卫生防范策略
Ann Glob Health. 2025 Jun 2;91(1):24. doi: 10.5334/aogh.4671. eCollection 2025.
3
SuFEx-enabled high-throughput medicinal chemistry for developing potent tamoxifen analogs as Ebola virus entry inhibitors.利用基于硫氟交换反应(SuFEx)的高通量药物化学方法开发强效他莫昔芬类似物作为埃博拉病毒进入抑制剂。
Front Immunol. 2025 Apr 28;16:1533037. doi: 10.3389/fimmu.2025.1533037. eCollection 2025.
4
Therapeutic advances in Marburg virus disease: from experimental treatments to vaccine development.马尔堡病毒病的治疗进展:从实验性治疗到疫苗研发
Ann Med Surg (Lond). 2025 Mar 28;87(5):2784-2799. doi: 10.1097/MS9.0000000000003213. eCollection 2025 May.
5
Immunogenicity, Pathogenesis, and Host's Immuno-Responses to Marburg Virus Infection.马尔堡病毒感染的免疫原性、发病机制及宿主免疫反应
Pathogens. 2025 Mar 27;14(4):323. doi: 10.3390/pathogens14040323.
6
Marburg Virus Disease: A Narrative Review.马尔堡病毒病:一篇叙述性综述。
Health Sci Rep. 2025 May 6;8(5):e70669. doi: 10.1002/hsr2.70669. eCollection 2025 May.
7
Viral interactions with host factors (TIM-1, TAM -receptors, Glut-1) are related to the disruption of glucose and ascorbate transport and homeostasis, causing the haemorrhagic manifestations of viral haemorrhagic fevers.病毒与宿主因子(TIM-1、TAM 受体、Glut-1)的相互作用与葡萄糖和抗坏血酸转运及体内平衡的破坏有关,从而导致病毒性出血热的出血表现。
F1000Res. 2024 Dec 9;12:518. doi: 10.12688/f1000research.134121.2. eCollection 2023.
8
A surrogate BSL2-compliant infection model recapitulating key aspects of human Marburg virus disease.一种符合生物安全水平2级要求的替代感染模型,概括了人类马尔堡病毒病的关键特征。
Emerg Microbes Infect. 2025 Dec;14(1):2449083. doi: 10.1080/22221751.2024.2449083. Epub 2025 Jan 12.
9
Epidemiological description of Marburg virus disease outbreak in Kagera region, Northwestern Tanzania.坦桑尼亚西北部卡盖拉地区马尔堡病毒病疫情的流行病学描述。
PLoS One. 2024 Sep 5;19(9):e0309762. doi: 10.1371/journal.pone.0309762. eCollection 2024.
10
N-Substituted Pyrrole-Based Heterocycles as Broad-Spectrum Filoviral Entry Inhibitors.基于 N-取代吡咯的杂环化合物作为广谱丝状病毒进入抑制剂。
J Med Chem. 2024 Aug 22;67(16):13737-13764. doi: 10.1021/acs.jmedchem.4c00527. Epub 2024 Aug 6.